VIELA BIO, INC. Comprehensive Income
VIELA BIO, INC. reported Comprehensive Income of -$150.59 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-03-01
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-12-31 was -$33.66M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-09-30 was -$37.95M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-06-30 was -$38.08M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-03-31 was -$40.90M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$150.59M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$86.42M.
- VIELA BIO, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$190.27M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$33.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$71.61M derived: sum of 2 quarters · filed 2021-03-01 | -$109.69M derived: sum of 3 quarters · filed 2021-03-01 | -$150.59M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$37.95M 10-Q · filed 2020-11-10 | -$76.03M derived: sum of 2 quarters · filed 2020-11-10 | -$116.93M 10-Q · filed 2020-11-10 | -$128.47M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | -$38.08M 10-Q · filed 2020-08-12 | -$78.98M 10-Q · filed 2020-08-12 | -$90.52M derived: sum of 3 quarters · filed 2021-03-01 | -$138.96M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | -$40.90M 10-Q · filed 2020-05-13 | -$52.44M derived: sum of 2 quarters · filed 2021-03-01 | -$100.88M derived: sum of 3 quarters · filed 2021-03-01 | -$106.35M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | -$11.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$59.98M derived: sum of 2 quarters · filed 2021-03-01 | -$65.45M derived: sum of 3 quarters · filed 2021-03-01 | -$86.42M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$48.44M 10-Q · filed 2020-11-10 | -$53.91M derived: sum of 2 quarters · filed 2020-11-10 | -$74.89M 10-Q · filed 2020-11-10 | -$89.94M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$5.47M 10-Q · filed 2020-08-12 | -$26.45M 10-Q · filed 2020-08-12 | -$41.50M derived: sum of 3 quarters · filed 2021-03-01 | -$57.19M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$20.98M 10-Q · filed 2020-05-13 | -$36.03M derived: sum of 2 quarters · filed 2021-03-01 | -$51.71M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$15.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$30.74M derived: sum of 2 quarters · filed 2021-03-01 | -$190.27M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$15.68M 10-Q · filed 2019-11-14 | -$175.22M 10-Q · filed 2019-11-14 |